Skip to main content

Table 5 Association of HIV status and DM2 status with soluble markers

From: No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

  ln (Adiponectin) ln (IL-6) ln (TNF- α) ln (sCD14)
Unadjusted
Β-coefficient
(95% CI)
Adjusted
Β-coefficient
(95%CI)
Unadjusted
p-interaction
Unadjusted
Β-coefficient
(95% CI)
Adjusted
Β-coefficient
(95%CI)
Unadjusted
p-interaction
Unadjusted
Β-coefficient
(95% CI)
Adjusted
Β-coefficient
(95%CI)
Unadjusted
p-interaction
Unadjusted
Β-coefficient
(95% CI)
Adjusted
Β-coefficient
(95%CI)
Unadjusted
p-interaction
HIV status −0.03 (− 0.24;0.18) 0.04 (− 0.16;0.24) 0.180 0.08 (− 0.28;0.45) 0.06 (− 0.32;0.44) 0.886 0.13 (− 0.07;0.32) 0.19 (0.04;0.35) 0.720 0.46 (0.26;0.65) 0.44 (0.22;0.66) 0.835
DM2 status − 0.45 (− 0.64;-0.27) − 047 (− 0.69;-0.26) 0.51 (0.16;0.85) 0.51 (0.09;0.92) 0.21 (0.02;0.40) 0.09 (− 0.08;0.26) 0.07 (− 0.15; 0.29) 0.08 (− 0.15;0.31)
  1. Multivariable models have been adjusted for age, sex and BMI. Abbreviations: IL-6 Interleukin-6, TNF- α Tumor necrosis factor-alfa, sCD14 Soluble CD14, DM2 Diabetes mellitus type 2